Hims Hers Health Inc株(ISIN: US4330001060)についての詳細は以下をご覧ください。このページの下にある過去データ、チャート、テクニカル分析といったセクションにて詳細を掲載しています。

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investing.com - テレヘルス企業Hims & Hers Health (NYSE: HIMS)の株価は、製薬大手ノボ・ノルディスク(NYSE: NVO)が減量薬販売に関する同社との提携を終了すると発表した後、32%急落した。 デンマークの製薬会社は月曜日、NovoCare Pharmacyを通じてFDA承認の減量薬Wegovyへの直接アクセスをHims & Hersに提供しないと ...

Despite Novo Nordisk (NVO) recently ending a partnership with Hims & Hers Health (NYSE:HIMS) to distribute its weight-loss ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...

Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make ...

Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow Hims & Hers to sell ...

The loss of Novo’s involvement significantly dented investor confidence in Hims & Hers, plunging shares in the latter by 35% ...

Novo Nordisk has announced it is ending its distribution collaboration with US telehealth firm Hims & Hers Health over the ...

The Novo Nordisk partnership ending does not alter my long-term bullish thesis on HIMS; the company is much more than just a ...

Hims & Hers Health, a telehealth company, offers direct-to-patient platform to distribute prescription drugs and OTC ...